rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. 1998

E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.

The rK39 enzyme-linked immunosorbent assay (ELISA) was compared with the direct agglutination test (DAT) for Leishmania donovani infection in the Sudan. rK39 ELISA proved more sensitive than DAT in diagnosis of kala-azar (93 and 80%, respectively); both tests may remain positive up to 24 months after treatment. For patients with post-kala-azar dermal leishmaniasis and individuals with subclinical infection, rK39 ELISA performed as well as DAT but could detect infection 6 months earlier in approximately 40% of patients. Conversion in DAT and rK39 ELISA also occurred in leishmanin skin test (LST)-positive individuals, suggesting active parasite replication (rK39 is an amastigote antigen) in these presumably immune individuals. In contrast to DAT, rK39 ELISA also detected infection in randomly selected LST-positive individuals (in four of six) and endemicity (LST-negative) controls (in one of five). rK39 ELISA appears more sensitive than DAT and may prove an important tool in epidemiological studies.

UI MeSH Term Description Entries
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000372 Agglutination Tests Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed) Agglutination Test,Test, Agglutination,Tests, Agglutination

Related Publications

E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
January 1991, Journal of clinical laboratory analysis,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
January 1982, Journal of clinical pathology,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
February 1987, European journal of clinical microbiology,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
October 2008, The American journal of tropical medicine and hygiene,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
February 1982, Journal of virological methods,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
February 1986, European journal of clinical microbiology,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
March 1991, The Southeast Asian journal of tropical medicine and public health,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
November 1987, Journal of clinical microbiology,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
January 1981, The Journal of pediatrics,
E E Zijlstra, and N S Daifalla, and P A Kager, and E A Khalil, and A M El-Hassan, and S G Reed, and H W Ghalib
February 1981, American journal of veterinary research,
Copied contents to your clipboard!